Nutrition Intervention in AIDS Wasting

Status Completed

Clinical Trial Summary

There are no guidelines for appropriate nutritional management of weight loss or wasting in HIV infection. Some treatments may increase weight, but without improving muscle mass or quality of life. In this clinical trial AIDS patients with wasting are randomized to one of three nutritional strategies and studied over a 12-week period: 1) optimal oral nutrition with counseling and protein and calorie supplementation, and a placebo pill; 2) optimal oral nutrition with the oral androgen, oxandrolone at 20 mg daily; and 3) optimal oral nutrition with progressive resistance training (PRT). In all participants, dietary intervention is maximized by weekly personalized counseling to address individual issues and concerns. Two primary outcomes are assessed: thigh muscle mass and quality of life. Our findings can be used to develop guidelines for standards of nutritional care among AIDS patient with the wasting syndrome.

Clinical Trial Description

n/a

Study Design

Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00006167
Study type	Interventional
Source	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Contact
Status	Completed
Phase	Phase 4
Start date	January 1998
Completion date	August 2000

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00000925` - A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss	Phase 2
Completed	`NCT00006064` - The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children	N/A
Completed	`NCT00001077` - A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements	N/A
Completed	`NCT00004664` - Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting	N/A
Completed	`NCT00489528` - Growth Hormone in the Treatment of HIV-Associated Wasting	Phase 3
Completed	`NCT00637572` - Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss	Phase 2
Completed	`NCT00000737` - A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome	Phase 1
Completed	`NCT00000854` - A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss	Phase 1
Completed	`NCT00002157` - Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome	N/A
Completed	`NCT00001079` - A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss	Phase 2
Completed	`NCT00002127` - A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome	Phase 2